Top Gynecology Congress 2025 | Best Women Health Conferences | Barcelona | Spain

Gynecology, Obstetrics, Reproductive health, Menstrual cycle, Pregnancy, Childbirth, Prenatal care, Postnatal care

Recommended Global Reproductive Medicine & Women Healthcare Webinars & Conferences

Europe & UK

Gynecology 2025, Italy

Asia Pacific & Middle East

Canada

GYNECOLOGY CONGRESS 2025

About Conference

The “10th International Conference on Gynecology and Women Health” promises to be a pivotal event, scheduled for May 14-15, 2025 in Barcelona, Spain. Under the theme “Novel Strategies and Future Endeavors in Gynecology and Women Health”, the hybrid event offers participants the flexibility to join either in person or online, making it accessible to a global audience.

The conference will spotlight the unique healthcare needs of women across various life stages, from adolescence to eldercare. As the world's largest congress dedicated to women's health, Gynecology Congress 2025 will cover clinical best practices, research advancements, and innovative trends in gynecology and Women Health. The program features symposiums, keynote sessions, and both oral and poster presentations on topics like infertility, breast cancer, and more. Attracting a diverse range of professionals, including researchers, gynecologists, and healthcare practitioners, the conference aims to provide a comprehensive and integrated approach to women's healthcare.

Sessions and Tracks

Track 01: Adolescent and Maternal Health

Adolescent and Maternal Health encompasses the medical and psychological care of young women transitioning into adulthood and those who are pregnant. It focuses on addressing unique health challenges such as reproductive health education, contraception, and prevention of pregnancy-related complications. Effective management aims to ensure optimal health outcomes for both adolescents and expectant mothers through comprehensive care, early intervention, and education.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 02: Drug Management during Pregnancy

Drug Management during Pregnancy involves carefully selecting and monitoring medications to ensure both maternal and fetal safety. It requires balancing the treatment of medical conditions with the potential risks of drug exposure to the developing fetus. Healthcare providers must consider the safety profiles of medications, potential side effects, and appropriate dosing to optimize outcomes for both mother and baby.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 03: Gynecologic Oncology

Gynecologic Oncology focuses on the diagnosis, treatment, and management of cancers affecting the female reproductive organs, including the ovaries, uterus, cervix, and vulva. Specialists in this field employ advanced techniques for early detection, surgical interventions, chemotherapy, and radiation therapy to improve survival rates and quality of life for patients.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 04: Gynecological Endocrinology

Gynecological Endocrinology deals with the study and treatment of hormone-related disorders affecting the female reproductive system. It addresses conditions such as irregular menstrual cycles, polycystic ovary syndrome (PCOS), and menopause by focusing on hormonal imbalances and their impact on reproductive health.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 05: Health Risks Associated with Surrogacy

Health Risks Associated with Surrogacy include potential complications for both the surrogate and the baby. Risks may involve pregnancy-related issues such as preterm birth, gestational diabetes, and hypertension for the surrogate, while the baby may face risks related to prenatal development and birth. Comprehensive medical monitoring and support are essential to mitigate these risks and ensure a healthy outcome.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 06: Impact of COVID-19 on Women’s Health

Impact of COVID-19 on Women’s Health includes increased risks of severe illness for pregnant women, disruptions to reproductive health services, and heightened mental health challenges. Women have experienced exacerbated health disparities, including impacts on access to care and economic strain, highlighting the need for targeted support and resources during the pandemic.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 07: PCOD & PCOS

PCOD & PCOS are hormonal disorders affecting women’s reproductive health. PCOS is characterized by irregular menstrual cycles, excess androgen levels, and ovarian cysts, leading to symptoms like infertility, acne, and weight gain. PCOD is a similar condition with a broader range of symptoms and less emphasis on cyst formation. Both require management to address hormonal imbalances and related health issues.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 08: Assisted Reproductive Technology

Assisted Reproductive Technology (ART) includes medical procedures used to help individuals conceive and build families. Techniques such as in vitro fertilization (IVF), intrauterine insemination (IUI), and egg or sperm donation are employed to address fertility issues and enhance the chances of pregnancy. ART provides options for those with infertility or genetic concerns.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 09: Endometriosis

Endometriosis is a chronic condition where tissue similar to the uterine lining grows outside the uterus, causing pain, irregular bleeding, and potential infertility. It can lead to significant discomfort and complications, and management typically involves medication, hormone therapy, and sometimes surgery to alleviate symptoms and improve quality of life.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 10: Ethical, Legal, and Social Issues

Ethical, Legal, and Social Issues in Women’s Health encompass challenges related to reproductive rights, access to care, and privacy. These issues involve ensuring informed consent, addressing disparities in healthcare access, and navigating ethical dilemmas surrounding reproductive technologies, maternal health, and gender-specific treatments.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 11: Infertility

Infertility refers to the inability to conceive after a year of regular, unprotected intercourse or the inability to carry a pregnancy to term. It can affect both men and women, with various causes including hormonal imbalances, structural issues, or lifestyle factors. Treatments may include medication, lifestyle changes, or assisted reproductive technologies.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 12: Reproductive Endocrinology

Reproductive Endocrinology focuses on the hormonal regulation of reproductive systems and disorders. It involves diagnosing and treating conditions affecting fertility, menstrual cycles, and hormone imbalances, using therapies to manage issues such as infertility, PCOS, and menopause.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 13: Reproductive Medicine & Reproductive Toxicology

Reproductive Medicine & Reproductive Toxicology explores the medical and environmental factors affecting reproductive health. Reproductive medicine addresses fertility issues and reproductive disorders, while reproductive toxicology studies how chemicals and environmental agents impact reproductive health and development. Both fields aim to improve outcomes and safety for individuals and future generations.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 14: Sexually Transmitted Diseases

Sexually Transmitted Diseases (STDs) are infections transmitted through sexual contact, including diseases like chlamydia, gonorrhea, and herpes. They can cause a range of symptoms, from mild to severe, and may lead to complications if untreated. Prevention through safe sex practices and regular screenings is crucial for managing and reducing their spread.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 15: Urogynaecology

Urogynaecology specializes in diagnosing and treating pelvic floor disorders affecting women, such as urinary incontinence and pelvic organ prolapse. It combines aspects of urology and gynecology to address conditions that impact bladder function and reproductive health, aiming to improve quality of life through both non-surgical and surgical interventions.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 16: Abnormal Uterine Bleeding

Abnormal Uterine Bleeding refers to irregular or excessive bleeding from the uterus, including heavy, prolonged, or unexpected bleeding. It can be caused by various factors such as hormonal imbalances, fibroids, or polyps. Accurate diagnosis and treatment are essential to manage symptoms and address underlying conditions.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 17: Maternal-Fetal Medicine

Maternal-Fetal Medicine focuses on the management and care of high-risk pregnancies. Specialists in this field monitor both maternal and fetal health, addressing complications such as preterm birth, gestational diabetes, and hypertension to optimize outcomes for both mother and baby.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 18: Multifetal Pregnancy

Multifetal Pregnancy involves carrying more than one fetus simultaneously, such as twins, triplets, or higher-order multiples. It presents increased risks for both the mother and babies, including preterm birth and complications. Careful monitoring and specialized management are essential to ensure the health and safety of both the mother and her infants.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 19: Preterm Birth and Prevention

Preterm Birth and Prevention focus on delivering a baby before 37 weeks of gestation, which can lead to health complications. Prevention strategies include managing risk factors, regular prenatal care, and interventions such as progesterone supplements or cervical cerclage. Timely medical support aims to reduce the likelihood of preterm birth and improve outcomes for the baby.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Track 20: Spontaneous Abortion and Miscarriage

Spontaneous Abortion and Miscarriage refer to the loss of a pregnancy before 20 weeks of gestation. Common causes include chromosomal abnormalities, hormonal imbalances, or uterine issues. Management involves emotional support, medical care, and understanding the underlying causes to address future pregnancy outcomes.

Related Worldwide Associations and Societies: American Gynecological & Obstetrical Society | The Association for Women's Health Care | Global Women's Health

Benefits of Participation

Benefits for Speaker

Gain global recognition for your research profile worldwide.
Earn professional credits to support your career advancement.
Stay updated with the latest advancements in cutting-edge research.
Foster lasting connections through social and networking events.
Promote your research effectively through a one-page ad featured in abstract books and flyers, reaching a million views and significantly enhancing your research profile.
Expand your knowledge beyond your core field of gynecology and women health by exploring new subjects and areas of study.
Experience a unique blend of networking, learning, and enjoyable interactions, all in one comprehensive package.

Benefits for Delegate

Enhance your professional development by deepening your understanding and knowledge.
Your involvement contributes to the development of innovative methodologies and ideologies that can expand business and industry outcomes.
Connect with fellow gynecology and women health summit researchers and experts, fostering opportunities to exchange fresh ideas and insights within the field.

Benefit for Sponsor

Immerse yourself in an international environment to enhance the potential for new company opportunities.
Showcase your company's latest technologies, new products, or services to a diverse global audience.
Boost your business growth by generating leads through active participation.
Building a successful company requires considerable time, effort, and determination. It's invaluable to have a network of colleagues and associates who share a common drive and objective to draw inspiration from.
Evaluate and advance your organizational strategies by benchmarking against leading industry plans.
Gain valuable insights and solutions to your company's questions and challenges through feedback from trusted experts during our webinars.
Elevate your company's branding and marketing through prominent placement of your company's logo on our banners, website, and other event materials.

Benefit for Collaborators

This is the premier platform globally for showcasing gynecology and women health to an extensive audience.
Cultivate enduring professional relationships.
Elevate your subscriber/member base by 40% through strategic placement of your organization's branding, marketing materials, promotional content, and logo on our banners, website, and event materials.
Listing your company in the Global Business forum will significantly amplify its exposure through our event.
Your representatives can engage in valuable networking opportunities to enhance their knowledge and understanding of your organization's services and offerings alongside key delegates.
Gynecology and Women Health advertising materials, including posters, brochures, pamphlets, and services, will be seamlessly integrated with information and distributed to hospitals, universities, societies, and researchers.

Who Should Attend?

Scientists and Professors
Gynecological Surgeons
Women’s Health Researchers
Healthcare Faculty
Registered Nurses
Medical College Staff
Gynecology Students, Scientists, Doctors, and Faculty
Medical Colleagues
Training Institutes
Software Development Companies
Medical Device Manufacturers
Data Management Firms
Junior Research Fellows
Healthcare Executives (Directors, Managers, CEOs)
Healthcare Associations and Societies
Business Entrepreneurs
Midwifery Educators
Nurse Practitioners
Gynecologists
Obstetricians
Infertility Specialists
Embryologists
Radiographers and Sonographers
Anesthesiologists

Market Analysis

The global women’s health market was valued at USD 44.36 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2030. This growth is driven by the aging female population and the emergence of advanced therapeutic products like Relugolix and Orilissa. Government policies aimed at enhancing women’s health and increasing awareness are expected to further boost market expansion. Although the market saw slower growth during the pandemic, it is anticipated to accelerate as conditions improve.